GAO Pushes FDA to Improve First Cycle Generic Approval Rate

In a report released Wednesday, the Government Accountability Office (GAO) calls on the US Food and Drug Administration (FDA) to take steps to improve the rate of first cycle approvals for generic drugs by increasing the clarity and consistency of reviewer comments.